Do Psychedelics Change Beliefs?
Hugh McGovern, Pantelis Leptourgos, Brendan Hutchinson, Philip R. Corlett
September 15, 2021 preprint DOI: 10.31234/osf.io/3dc2h (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Keywords | Flourishing Affect linguistics Cognition Consumption sociology Social science |
| Citations | 4 |
| Key findings | Psychedelics may not induce de novo beliefs but rather change the impact of affect and others' suggestions on how beliefs are imputed, with baseline beliefs potentially coloring acute and long-term effects. |
Abstract
Renewed interest in psychedelics has reignited the debate about whether and how they change human beliefs. In both the clinical and social-cognitive domains, psychedelic consumption may be accompanied by profound, and sometimes lasting, belief changes. We review these changes and their possible underlying mechanisms. Rather than inducing de novo beliefs, we argue psychedelics may instead change the impact of affect and of others’ suggestions on how beliefs are imputed. Critically, we find that baseline beliefs (in the possible effects of psychedelics, for example) might color the acute effects of psychedelics as well as longer term changes. If we are to harness the apparent potential of psychedelics in the clinic and for human flourishing more generally, these possibilities must be addressed empirically.
Citations in the library
Cited by 3
- Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency Frontiers in Psychology December 10, 2021
- How Level is the 'Cognitive Playing Field'? Philosophy and the Mind Sciences April 19, 2022
- Belief change and agnostic frames in psychedelic research and clinical contexts Philosophical Perspectives on Psychedelic Psychiatry September 13, 2024
Cites 49
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
and 44 more in the library